VeriSeq™ NIPT Solution v2
Comprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.
Receive your quote directly from the manufacturer.
The VeriSeq NIPT Solution v2 is an in vitro diagnostic test intended for use as a screening test for the detection of genome-wide fetal genetic anomalies from maternal peripheral whole blood specimens in pregnant women of at least 10 weeks gestation. VeriSeq NIPT Solution v2 uses whole-genome sequencing to detect partial duplications and deletions for all autosomes and aneuploidy status for all chromosomes.
For In Vitro Diagnostic Use
Contact an Illumina representative for regional availability.
VeriSeq NIPT Solution v2
In this data sheet, Illumina presents the VeriSeq NIPT Solution v2, a non-invasive prenatal testing (NIPT) solution using next-generation sequencing for comprehensive fetal genome screening. By combining an extensive test menu, high accuracy, low failure rates, and integrated reagents, instruments, software, and training, the solution enables labs to perform reliable in-house NIPT and support timely pregnancy management decisions.
